ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

AFMD Affimed NV

5.30
0.00 (0.00%)
プレマーケット
最終更新日: 17:00:00
15分遅延
名称 銘柄コード 市場 種別
Affimed NV AFMD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 5.30 17:00:00
始値 安値 高値 終値 前日終値
5.30
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2417:05GLOBEAffimed Announces Acceptance of AFM24 Clinical Abstract at..
2024/3/2819:30GLOBEAffimed Reports 2023 Financial Results and Operational..
2024/3/2119:30GLOBEAffimed To Report Full Year 2023 Financial Results &..
2024/3/1205:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0620:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0620:30GLOBEAffimed Announces 1-for-10 Reverse Stock Split
2024/1/0906:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0906:05GLOBEAffimed Provides Clinical Response Update on AFM24-102 Trial..
2024/1/0822:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0822:00GLOBEAffimed Announces Leadership Change and Organizational..
2024/1/0320:30GLOBEAffimed Announces Sale of Wholly-Owned Subsidiary AbCheck
2023/12/1120:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1120:02GLOBEAffimed Announces Positive Data for AFM24 in Combination..
2023/12/1120:00GLOBEAffimed Announces Updated Phase 1/2 Data from Acimtamig in..
2023/12/0420:30GLOBEAffimed to Host Investor Conference Call Highlighting..
2023/11/3021:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1420:30GLOBEAffimed Reports Third Quarter 2023 Financial Results and..
2023/11/0920:30GLOBEAffimed Announces Acimtamig as International Nonproprietary..
2023/11/0720:30GLOBEAffimed to Report Third Quarter 2023 Financial Results &..
2023/11/0401:05GLOBEAffimed Presents Preclinical Data Showing that Addition of..
2023/11/0222:05GLOBEAffimed Announces Oral Presentation of Phase 1/2 Data from..
2023/11/0119:30GLOBEAffimed to Participate in Upcoming Investor Conferences
2023/10/0419:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0419:30GLOBEAffimed Announces Listing Transfer to Nasdaq Capital Markets
2023/9/2722:05GLOBEAffimed Announces Acceptance of an Abstract Comparing NK..
2023/9/2119:30GLOBEAffimed to Present at the Cantor Global Healthcare..
2023/9/1219:30GLOBEAffimed Receives FDA Fast Track Designation for AFM13 in..
2023/9/0719:30GLOBEAffimed to Present at the H.C. Wainwright Annual Global..
2023/8/2218:00GLOBEAffimed Announces Publication in the Journal mAbs on..
2023/8/1019:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1019:30GLOBEAffimed Reports Second Quarter 2023 Financial Results and..
2023/8/0319:30GLOBEAffimed to Report Second Quarter 2023 Financial Results..
2023/8/0106:05GLOBEAffimed Announces an ASCO Breakthrough Poster Presentation..
2023/6/2219:30GLOBEAffimed Announces Addition of Dr. Constanze Ulmer-Eilfort to..
2023/6/1006:59GLOBEAffimed Announces Acceptance of Abstracts at the 17th..
2023/6/0322:00GLOBEAffimed Presents AFM24 Monotherapy Data in Non-Small Cell..
2023/5/3019:30GLOBEAffimed to Present at the 2023 Jefferies Healthcare..
2023/5/2606:00GLOBEAffimed Announces Publication of AFM24 Clinical Abstracts..
2023/5/2319:30GLOBEAffimed Reports First Quarter 2023 Financial Results and..
2023/5/2319:15GLOBEAffimed Announces IND Clearance for a Phase 2 Clinical Trial..
2023/5/2219:30GLOBEAffimed Announces Annual General Meeting of Shareholders
2023/5/1619:30GLOBEAffimed to Report First Quarter 2023 Financial Results &..
2023/5/1123:05GLOBEAffimed Announces Abstracts at the Annual Meeting of the..

最近閲覧した銘柄

Delayed Upgrade Clock